purchase customization

1 Introduction to Research & Analysis Reports
1.1 Cell Therapy and Tissue Engineering Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell Therapy and Tissue Engineering Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell Therapy and Tissue Engineering Overall Market Size
2.1 Global Cell Therapy and Tissue Engineering Market Size: 2022 VS 2030
2.2 Global Cell Therapy and Tissue Engineering Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell Therapy and Tissue Engineering Players in Global Market
3.2 Top Global Cell Therapy and Tissue Engineering Companies Ranked by Revenue
3.3 Global Cell Therapy and Tissue Engineering Revenue by Companies
3.4 Top 3 and Top 5 Cell Therapy and Tissue Engineering Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell Therapy and Tissue Engineering Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Players in Global Market
3.6.1 List of Global Tier 1 Cell Therapy and Tissue Engineering Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell Therapy and Tissue Engineering Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell Therapy and Tissue Engineering Market Size Markets, 2022 & 2030
4.1.2 Cell Therapy
4.1.3 Tissue Engineering
4.2 By Type - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
4.2.1 By Type - Global Cell Therapy and Tissue Engineering Revenue, 2018-2023
4.2.2 By Type - Global Cell Therapy and Tissue Engineering Revenue, 2024-2030
4.2.3 By Type - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell Therapy and Tissue Engineering Market Size, 2022 & 2030
5.1.2 Cell Defects
5.1.3 Genetic Diseases
5.1.4 Neurodegenerative Diseases
5.1.5 Tissue Malignancies
5.1.6 Others
5.2 By Application - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
5.2.1 By Application - Global Cell Therapy and Tissue Engineering Revenue, 2018-2023
5.2.2 By Application - Global Cell Therapy and Tissue Engineering Revenue, 2024-2030
5.2.3 By Application - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cell Therapy and Tissue Engineering Market Size, 2022 & 2030
6.2 By Region - Global Cell Therapy and Tissue Engineering Revenue & Forecasts
6.2.1 By Region - Global Cell Therapy and Tissue Engineering Revenue, 2018-2023
6.2.2 By Region - Global Cell Therapy and Tissue Engineering Revenue, 2024-2030
6.2.3 By Region - Global Cell Therapy and Tissue Engineering Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cell Therapy and Tissue Engineering Revenue, 2018-2030
6.3.2 US Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.3.3 Canada Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.3.4 Mexico Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cell Therapy and Tissue Engineering Revenue, 2018-2030
6.4.2 Germany Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.3 France Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.4 U.K. Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.5 Italy Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.6 Russia Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.7 Nordic Countries Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.4.8 Benelux Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cell Therapy and Tissue Engineering Revenue, 2018-2030
6.5.2 China Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.5.3 Japan Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.5.4 South Korea Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.5.5 Southeast Asia Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.5.6 India Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cell Therapy and Tissue Engineering Revenue, 2018-2030
6.6.2 Brazil Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.6.3 Argentina Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell Therapy and Tissue Engineering Revenue, 2018-2030
6.7.2 Turkey Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.7.3 Israel Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.7.4 Saudi Arabia Cell Therapy and Tissue Engineering Market Size, 2018-2030
6.7.5 UAE Cell Therapy and Tissue Engineering Market Size, 2018-2030
7 Cell Therapy and Tissue Engineering Companies Profiles
7.1 Betalin Therapeutics
7.1.1 Betalin Therapeutics Company Summary
7.1.2 Betalin Therapeutics Business Overview
7.1.3 Betalin Therapeutics Cell Therapy and Tissue Engineering Major Product Offerings
7.1.4 Betalin Therapeutics Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.1.5 Betalin Therapeutics Key News & Latest Developments
7.2 BioCardia, Inc
7.2.1 BioCardia, Inc Company Summary
7.2.2 BioCardia, Inc Business Overview
7.2.3 BioCardia, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.2.4 BioCardia, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.2.5 BioCardia, Inc Key News & Latest Developments
7.3 BioReliance Corporation
7.3.1 BioReliance Corporation Company Summary
7.3.2 BioReliance Corporation Business Overview
7.3.3 BioReliance Corporation Cell Therapy and Tissue Engineering Major Product Offerings
7.3.4 BioReliance Corporation Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.3.5 BioReliance Corporation Key News & Latest Developments
7.4 Biosolution Co.
7.4.1 Biosolution Co. Company Summary
7.4.2 Biosolution Co. Business Overview
7.4.3 Biosolution Co. Cell Therapy and Tissue Engineering Major Product Offerings
7.4.4 Biosolution Co. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.4.5 Biosolution Co. Key News & Latest Developments
7.5 Brainstorm Cell Therapeutics, Inc
7.5.1 Brainstorm Cell Therapeutics, Inc Company Summary
7.5.2 Brainstorm Cell Therapeutics, Inc Business Overview
7.5.3 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.5.4 Brainstorm Cell Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.5.5 Brainstorm Cell Therapeutics, Inc Key News & Latest Developments
7.6 MaxCyte, Inc
7.6.1 MaxCyte, Inc Company Summary
7.6.2 MaxCyte, Inc Business Overview
7.6.3 MaxCyte, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.6.4 MaxCyte, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.6.5 MaxCyte, Inc Key News & Latest Developments
7.7 Medigene AG
7.7.1 Medigene AG Company Summary
7.7.2 Medigene AG Business Overview
7.7.3 Medigene AG Cell Therapy and Tissue Engineering Major Product Offerings
7.7.4 Medigene AG Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.7.5 Medigene AG Key News & Latest Developments
7.8 MEDIPOST CO.
7.8.1 MEDIPOST CO. Company Summary
7.8.2 MEDIPOST CO. Business Overview
7.8.3 MEDIPOST CO. Cell Therapy and Tissue Engineering Major Product Offerings
7.8.4 MEDIPOST CO. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.8.5 MEDIPOST CO. Key News & Latest Developments
7.9 Mesoblast Limited
7.9.1 Mesoblast Limited Company Summary
7.9.2 Mesoblast Limited Business Overview
7.9.3 Mesoblast Limited Cell Therapy and Tissue Engineering Major Product Offerings
7.9.4 Mesoblast Limited Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.9.5 Mesoblast Limited Key News & Latest Developments
7.10 Miromatrix Medical, Inc.
7.10.1 Miromatrix Medical, Inc. Company Summary
7.10.2 Miromatrix Medical, Inc. Business Overview
7.10.3 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.10.4 Miromatrix Medical, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.10.5 Miromatrix Medical, Inc. Key News & Latest Developments
7.11 MolMed S.p.A
7.11.1 MolMed S.p.A Company Summary
7.11.2 MolMed S.p.A Business Overview
7.11.3 MolMed S.p.A Cell Therapy and Tissue Engineering Major Product Offerings
7.11.4 MolMed S.p.A Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.11.5 MolMed S.p.A Key News & Latest Developments
7.12 Mustang Bio, Inc
7.12.1 Mustang Bio, Inc Company Summary
7.12.2 Mustang Bio, Inc Business Overview
7.12.3 Mustang Bio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.12.4 Mustang Bio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.12.5 Mustang Bio, Inc Key News & Latest Developments
7.13 NantKwest, Inc.
7.13.1 NantKwest, Inc. Company Summary
7.13.2 NantKwest, Inc. Business Overview
7.13.3 NantKwest, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.13.4 NantKwest, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.13.5 NantKwest, Inc. Key News & Latest Developments
7.14 Neuralstem, Inc
7.14.1 Neuralstem, Inc Company Summary
7.14.2 Neuralstem, Inc Business Overview
7.14.3 Neuralstem, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.14.4 Neuralstem, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.14.5 Neuralstem, Inc Key News & Latest Developments
7.15 NexImmune, Inc.
7.15.1 NexImmune, Inc. Company Summary
7.15.2 NexImmune, Inc. Business Overview
7.15.3 NexImmune, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.15.4 NexImmune, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.15.5 NexImmune, Inc. Key News & Latest Developments
7.16 Nohla Therapeutics, Inc
7.16.1 Nohla Therapeutics, Inc Company Summary
7.16.2 Nohla Therapeutics, Inc Business Overview
7.16.3 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.16.4 Nohla Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.16.5 Nohla Therapeutics, Inc Key News & Latest Developments
7.17 ReNeuron Group plc
7.17.1 ReNeuron Group plc Company Summary
7.17.2 ReNeuron Group plc Business Overview
7.17.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Major Product Offerings
7.17.4 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.17.5 ReNeuron Group plc Key News & Latest Developments
7.18 Richter-Helm BioLogics GmbH & Co. KG
7.18.1 Richter-Helm BioLogics GmbH & Co. KG Company Summary
7.18.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
7.18.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Major Product Offerings
7.18.4 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.18.5 Richter-Helm BioLogics GmbH & Co. KG Key News & Latest Developments
7.19 RoosterBio, Inc
7.19.1 RoosterBio, Inc Company Summary
7.19.2 RoosterBio, Inc Business Overview
7.19.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.19.4 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.19.5 RoosterBio, Inc Key News & Latest Developments
7.20 RoslinCT
7.20.1 RoslinCT Company Summary
7.20.2 RoslinCT Business Overview
7.20.3 RoslinCT Cell Therapy and Tissue Engineering Major Product Offerings
7.20.4 RoslinCT Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.20.5 RoslinCT Key News & Latest Developments
7.21 Rubius Therapeutics, Inc.
7.21.1 Rubius Therapeutics, Inc. Company Summary
7.21.2 Rubius Therapeutics, Inc. Business Overview
7.21.3 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.21.4 Rubius Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.21.5 Rubius Therapeutics, Inc. Key News & Latest Developments
7.22 Sangamo Therapeutics, Inc
7.22.1 Sangamo Therapeutics, Inc Company Summary
7.22.2 Sangamo Therapeutics, Inc Business Overview
7.22.3 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.22.4 Sangamo Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.22.5 Sangamo Therapeutics, Inc Key News & Latest Developments
7.23 Voyager Therapeutics, Inc
7.23.1 Voyager Therapeutics, Inc Company Summary
7.23.2 Voyager Therapeutics, Inc Business Overview
7.23.3 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.23.4 Voyager Therapeutics, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.23.5 Voyager Therapeutics, Inc Key News & Latest Developments
7.24 Waisman Biomanufacturing
7.24.1 Waisman Biomanufacturing Company Summary
7.24.2 Waisman Biomanufacturing Business Overview
7.24.3 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Major Product Offerings
7.24.4 Waisman Biomanufacturing Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.24.5 Waisman Biomanufacturing Key News & Latest Developments
7.25 WindMIL Therapeutics, Inc.
7.25.1 WindMIL Therapeutics, Inc. Company Summary
7.25.2 WindMIL Therapeutics, Inc. Business Overview
7.25.3 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.25.4 WindMIL Therapeutics, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.25.5 WindMIL Therapeutics, Inc. Key News & Latest Developments
7.26 Wuxi App Tec, Inc.
7.26.1 Wuxi App Tec, Inc. Company Summary
7.26.2 Wuxi App Tec, Inc. Business Overview
7.26.3 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Major Product Offerings
7.26.4 Wuxi App Tec, Inc. Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.26.5 Wuxi App Tec, Inc. Key News & Latest Developments
7.27 ReNeuron Group plc
7.27.1 ReNeuron Group plc Company Summary
7.27.2 ReNeuron Group plc Business Overview
7.27.3 ReNeuron Group plc Cell Therapy and Tissue Engineering Major Product Offerings
7.27.4 ReNeuron Group plc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.27.5 ReNeuron Group plc Key News & Latest Developments
7.28 Richter-Helm BioLogics GmbH & Co. KG
7.28.1 Richter-Helm BioLogics GmbH & Co. KG Company Summary
7.28.2 Richter-Helm BioLogics GmbH & Co. KG Business Overview
7.28.3 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Major Product Offerings
7.28.4 Richter-Helm BioLogics GmbH & Co. KG Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.28.5 Richter-Helm BioLogics GmbH & Co. KG Key News & Latest Developments
7.29 RoosterBio, Inc
7.29.1 RoosterBio, Inc Company Summary
7.29.2 RoosterBio, Inc Business Overview
7.29.3 RoosterBio, Inc Cell Therapy and Tissue Engineering Major Product Offerings
7.29.4 RoosterBio, Inc Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.29.5 RoosterBio, Inc Key News & Latest Developments
7.30 RoslinCT
7.30.1 RoslinCT Company Summary
7.30.2 RoslinCT Business Overview
7.30.3 RoslinCT Cell Therapy and Tissue Engineering Major Product Offerings
7.30.4 RoslinCT Cell Therapy and Tissue Engineering Revenue in Global Market (2018-2023)
7.30.5 RoslinCT Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer